Difficulty: Medium
Average Score: 81%
Practice
With regard to oral anti-asthmatic agents:
Correct answer
C
Rationale
Prednisone is intermediate-acting (12-36 hours), not long-acting like dexamethasone, so that's false. Methotrexate benefits some prednisone-dependent asthmatics, not all studies, making that false. Cyclosporin's toxicity (e.g., nephrotoxicity) limits its anti-asthmatic use, a true statement, despite immunosuppressive potential. Nifedipine has minimal effect on exercise-induced bronchoconstriction, unlike inhaled CCBs, so that's false. Macrolides show some benefit in asthma. Cyclosporin's limitation reflects its risk-benefit profile, restricting its practical use.